Skip to main content

Advertisement

Erratum to: Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

The original article was published in BMC Medicine 2013 11:43

Correction

The authors [1] note that the standard errors in Table 3 (Table 1 here) are actually standard deviations. The reference to standard errors in the footnote has now been edited accordingly.

This is a Correction article on http://www.biomedcentral.com/1741-7015/11/43.

Table 1 Summary of laboratory parameters

References

  1. 1.

    Bailey CJ, Gross JL, Hennicken D, Iqbal N, Mansfield TA, List JF: Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial. BMC Medicine. 2013, 11: 43-10.1186/1741-7015-11-43.

Pre-publication history

  1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1741-7015/11/193/prepub

Download references

Author information

Correspondence to Clifford J Bailey.

Additional information

The online version of the original article can be found at 10.1186/1741-7015-11-43

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article